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Sonic Hedgehog (Shh)-deficient mice have a severe lung branching defect. Recent studies have shown that hedgehog signaling is involved in
vascular development and it is possible that the diminished airway branching in Shh-deficient mice is due to abnormal pulmonary vasculature
formation. Therefore, we investigated the role of Shh in pulmonary vascular development using Shh/Tie2lacZ compound mice, which exhibit
endothelial cell-specific LacZ expression, and Pecam-1 immunohistochemistry. In E11.5–13.5 Shh-deficient mice, the pulmonary vascular bed is
decreased, but appropriate to the decrease in airway branching. However, when E12.5 Shh-deficient lungs were cultured for 4–6 days, the vascular
network deteriorated compared to wild-type lungs. The expression of vascular endothelial growth factor (Vegf) or its receptor Vegfr2 (KDR/Flk-1)
was not different between E12.5–13.5 Shh-deficient and wild-type lungs. In contrast, angiopoietin-1 (Ang1), but not Ang2 or the angiopoietin
receptor Tie2, mRNA expression was downregulated in E12.5–E13.5 lungs of Shh null mutants. Recombinant Ang1 alone was unable to restore
in vitro branching morphogenesis in Shh-deficient lungs. Conversely, the angiogenic factor fibroblast growth factor (Fgf)-2 alone or in
combination with Ang1, increased vascularization and tubular growth and branching of Shh-deficient lungs in vitro. The angiogenic factors did
not overcome the reduced smooth muscle cell differentiation in the Shh null lungs. These data indicate that early vascular development, mediated
by Vegf/Vegfr2 signaling proceeds normally in Shh-deficient mice, while later vascular development and stabilization of the primitive network
mediated by the Ang/Tie2 signaling pathway are defective, resulting in an abnormal vascular network. Stimulation of vascularization with
angiogenic factors such as Fgf2 and Ang1 partially restored tubular growth and branching in Shh-deficient lungs, suggesting that vascularization is
required for branching morphogenesis.
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The lung is composed of a complex network of airways
and vessels and although much has been learned regarding
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doi:10.1016/j.ydbio.2006.11.029during lung development remain somewhat obscure. Three
processes are believed to control pulmonary vascular
development: angiogenesis, which is defined as sprouting
of new vessels from pre-existing ones and gives rise to the
central vessels; vasculogenesis, which is de novo synthesis
of blood vessels from blood lakes in the periphery of the
lung; and the fusion of proximal and peripheral vessels to
form the pulmonary circulation (Risau, 1997; Risau and
Flamme, 1995; deMello et al., 1997). The importance of
the three processes for pulmonary vasculature development
remains to be elucidated (Schachtner et al., 2000; Parera et
al., 2005).
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play a passive role in pulmonary development. However,
recent studies have highlighted the importance of endothelial
cells for liver and pancreas organogenesis as well as cell
differentiation (Matsumoto et al., 2001; Lammert et al.,
2003). Furthermore, ample studies suggest that pulmonary
vascular development and airway branching morphogenesis
are linked, specifically during the period of alveolar
formation. Mice engineered to express only the vascular
endothelial growth factor (Vegf)-120 isoform, develop to
term, but die shortly after birth (Galambos et al., 2002). The
lungs showed impaired peripheral vascular development, a
reduced number of air–blood barriers, and delayed airspace
formation, suggesting a role for the heparin-binding Vegf
isoforms (164 and 188) in lung branching morphogenesis,
either directly or indirectly via vascularization. Likewise,
neonatal mice that were treated with a soluble decoy receptor
for Vegf (mFlt(1–3)-IgG) to block endogenous Vegf signal-
ing exhibited an overall dramatic decrease in body and organ
growth and died within 4–6 days after birth (Gerber et al.,
1999). The lungs of these mice were immature with
simplification of the alveolar region and a decrease in
pulmonary arterial density. In addition, inhibition of
vasculogenesis in rat pups with the Vegf receptor (Vegfr)
blocker, Su-5416, or Vegfr neutralizing antibodies resulted in
reduced alveolarization (Jakkula et al., 2002; Le Cras et al.,
2002; McGrath-Morrow et al., 2005). Similarly, inhibition of
neovascularization in an embryonic lung allograft model with
endothelial monocyte activating polypeptide (Emap II), an
anti-angiogenic protein, resulted in lung hypoplasia and
arrest of airway epithelial morphogenesis at the canalicular
stage of lung development (Schwarz et al., 2000). Although
these data indicate a linkage between distal airway and
vascular formation during the later stages of pulmonary
development, it is unknown whether these processes are
linked during early lung branching morphogenesis.
Sonic hedgehog (Shh) is an important morphogen known
to regulate epithelial–mesenchymal interactions during
embryonic development, including the lung (Bellusci et al.,
1997a,b; Litingtung et al., 1998; Pepicelli et al., 1998). Shh-
deficient mice exhibit a severe lung branching defect
(Litingtung et al., 1998; Pepicelli et al., 1998). Recently,
evidence has emerged that Shh is able to induce robust
angiogenesis in vivo (Pola et al., 2003). Shh is also essential
for coronary vascular development (Lavine et al., 2006). In
vitro, Shh has been shown to induce capillary morphogenesis
of endothelial cells (Kanda et al., 2003). Shh induces the
expression of two families of angiogenic cytokines, including
all three Vegf isoforms and Ang1 and 2 (Pola et al., 2001).
Furthermore, Vegf acts downstream of Shh signaling in
arterial cell fate determination (Lawson et al., 2002). Thus, it
is possible that the reduced airway branching in Shh null
mice is secondary to a defect in pulmonary vasculature
formation. This possibility is supported by a recent study
showing that Shh null lung have less Pecam-1 (platelet
endothelial cell adhesion molecule-1, an endothelial cell
marker)-positive cells (Miller et al., 2004).Herein, we investigated the vascular development in Shh-
deficient lungs and observed that the early pulmonary
vasculature develops normally but that the vascular network
deteriorates at later stages of development, which may be due to
decreased levels of Ang1. Exogenous Fgf2 in combination with
Ang1 stimulated vascularization as well as tubular growth and
branching of Shh-deficient lungs, suggesting that vasculariza-
tion is crucial for normal branching morphogenesis.
Materials and methods
Mouse mutants
Shh, Gli2 and Gli3 heterozygous (Shh+/−, Gli2+/−, Gli3+/−) mice were
obtained from Dr. C.C. Hui, Hospital for Sick Children, Toronto, Ontario. Tie2-
LacZ mice (Schlaeger et al., 1998) were obtained from Jackson Laboratory, Bar
Harbor, MN. Shh+/−, Gli2+/−, Gli3+/− mice were crossed with Tie2-LacZ mice
and embryos obtained from crossings between Shh+/−/Tie2-LacZ, Gli2+/−/Tie-
LacZ, Gli3+/−/Tie2-LacZ compound mice were used for whole mount LacZ
staining of E11.5–E13.5 lungs and whole organ cultures of E12.5 lungs. The
Shh, Gli2, and Gli3 genotypes were established by PCR analysis of genomic
DNA (Chiang et al., 1996).
Whole lung organ culture
Lung buds were dissected from E12.5 Shh/Tie2-LacZ embryos (day of
vaginal plug is E0.5) and placed on a floating 8-μm Whatman Nucleopore
polycarbonate membrane (Integra Environmental Inc., Burlington, ON).
Explants were grown in DMEM/2% FCS (Gibco, Grand Islands, NY), and
maintained in 20% O2, 5% CO2, at 37 °C. Ang1 (R&D, Minneapolis, MN) and
Fgf2 (Promega, Madison, WI) were added to the medium at a concentration of
500 ng/ml and 250 ng/ml, respectively. Medium and growth factors were
changed every other day.
Mesenchyme-free lung endodermal bud culture
Lungs were dissected from E12 embryos and transferred to Hanks balanced
salt solution [HBSS(−)]. The lungs were treated with 20% (v/v) Dispase (Gibco,
Grand Islands, NY) for 30 min at 37 °C in order to loosen the tissue layers.
Following neutralization of enzyme activity with FCS the endodermal and
mesodermal components at the tips of the lung buds were separated manually
under a dissection microscope using 27-gauge needles. The distal endodermal
buds were then embedded in 300 μl Growth Factor Reduced Matrigel (BD
Biosciences, Bedford, MA) diluted 1:1 in DMEM containing either 200 μg/ml
Fgf1, Fgf2 or Fgf7 (R&D, Minneapolis, MN). For sectioning, lung bud cultures
were fixed overnight in ice-cold 70% (v/v) ethanol, dehydrated and embedded in
paraplast. Sections (7 μm) were stained with Carazzi hematoxylin and pictures
were taken using a Leica digital imaging system.
LacZ staining
Shh/Tie2-LacZ, Gli2/Tie-LacZ, and Gli3/Tie-LacZ lungs and Shh/Tie2-
LacZ explants were fixed (4 °C), washed and stained (37 °C) with X-gal. For
sectioning, lungs were fixed in 4% (w/v) paraformaldehyde (PFA) in phosphate-
buffered saline (PBS), dehydrated and embedded in paraplast. Sections (7 μm)
were mounted onto Superfrost slides (Fisher Scientific, Unionville, ON).
Pictures were taken using a Leica digital imaging system.
Immunohistochemistry
Lungs were dissected from E11.5–E14.5 Shh+/+, Shh+/− and Shh−/−
embryos, fixed overnight in 4% PFA in PBS, dehydrated and embedded in
paraplast. Endogenous peroxidase activity was quenched with 0.15% (v/v)
hydrogen peroxide in methanol. Antigen retrieval for Pecam-1 staining was
achieved with trypsin (0.6 mg/ml) treatment for 5 min at room temperature
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Sma) staining. Non-specific binding sites were blocked using 5% (v/v)
normal goat serum and 1% (w/v) bovine serum albumin followed by
overnight incubation at 4 °C with rat anti-mouse Pecam-1 antibody (1:60;
anti-CD31; Pharmingen) or mouse monoclonal α-Sma antibody (1:1000;
Neomarkers, Fremont, CA). Sections were subsequently incubated with
biotinylated secondary antibodies at RT. Color detection was performed
according to instructions in the Vectastain ABC and DAB kit (Vector
Laboratories, Burlingname, CA). Slides were lightly counterstained with
Carazzi hematoxylin.
RNA isolation and real-time RT-PCR
Total RNA (1 μg) extracted from E12.5 (8 Shh+/+, 17 Shh+/− and 17 Shh−/−;
total of 2 sets) and E13.5 (14 Shh+/+, 17 Shh+/− and 19 Shh−/−; total of 4 sets)Fig. 1. Vascular development in early Shh−/− lungs. (A–C) X-gal stained lungs of Sh
of a wild-type (Shh+/+) embryo (A). Although Shh−/− lungs (C) are much smaller th
in Shh−/− lungs. (D–F) X-gal stained lungs of Shh/Tie2-LacZ mice at E13.5 days. At
(E) lungs; large vessels are running along the trachea (arrows), whereas a dense netw
(arrowheads). In the Shh−/− lung (F), a comparable dense network covers the entire p
the tracheoesophageal tube (arrow). Note the small size of Shh−/− lungs (F) compared
Tie2-lacZ lungs. Larger vessels are seen in all three lungs (arrows). A comparable
epithelial tubules of Shh+/+ (G), Shh+/− (H) and Shh−/− (I) lungs. Intravascular r
counterstained with eosin. Blue color is positive X-gal staining in endothelial cells.lungs using the RNA easy kit (Qiagen, Mississauga) was reverse transcribed
using random hexamers (Applied Biosystems, Foster City, CA, USA). The
resulting templates (50 ng of cDNA for our target genes and 5 ng for 18 S) were
quantified by real-time PCR (ABI Prism 7700). Primers and TaqMan probes for
total Vegf, Vegf120, Vegf164, Vegf188, Ang1, Ang2 were similar to previously
published sequences (Elson et al., 2001) while primers and TaqMan probes for
Pecam-1, Tie2, Fgf2, Fgf10 and Fgfr2 were purchased from ABI as Assays-on-
Demand™ for murine genes. For each probe a dilution series determined the
efficiency of amplification of each primer/probe set and the relative
quantification method employed (Livak and Schmittgen, 2001). For the relative
quantitation, PCR signals were compared between groups after normalization
using 18 S as an internal reference. Briefly, relative expression was calculated as
2− (Ctgene of interest-Ct18S). Fold change was calculated according to Livak and
Schmittgen (2001). Data are presented as mean±SEM. A p<0.05 was
considered statistically significant.h/Tie2-LacZ mice at E11.5. A complex vascular network is present in the lung
an Shh+/+ (A) and Shh+/− (B) lungs, an appropriate vascular network is found
E13.5, the vascular network has extended dramatically in Shh+/+ (D) and Shh+/−
ork of microvessels cover the proximal (bronchiolar) and distal (alveolar) areas
ulmonary area (arrowheads) whereas larger vessels are present on both sides of
to Shh+/+ (D) and Shh+/− (E) lungs. (G–I) Sections (12 μm) of X-gal stained Shh/
microvascular network is found in the mesenchyme surrounding the primitive
ed blood cells are detected in all three sections (arrowheads). Sections were
Scale bar: (A–C) 100 μm; (D, F) 250 μm; (E) 100 μm; (G–I) 100 μm.
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LacZ staining of Shh-deficient lungs
Whole mount LacZ staining revealed that the lungs of both
wild-type (Shh+/+) and heterozygous (Shh+/−) mice had already
a highly branched network of vessels at E11.5 (Figs. 1A and B),
which became very complex at E13.5 (Figs. 1D and E). After
sectioning of the E13.5 LacZ stained lungs we observed that the
vessels ran close and around the developing airways of the
Shh+/+ and Shh+/− lungs (Figs. 1G and H). In Shh-deficient
(Shh−/−) mice, lung hypoplasia was noticeable as early as E11.5
(Fig. 1C). Whole mount LacZ staining demonstrated, however,
an extensive vascular network in the mesenchyme surrounding
the developing lung buds (Fig. 1C), similar to the pattern seen in
Shh+/+ and Shh+/− lungs. Lung hypoplasia and reduced airway
branching morphogenesis were more evident in E13.5 Shh−/−
mice (Fig. 1F). The vascular network, however, was abundantFig. 2. Pecam-1 immunostaining in early Shh−/− lungs. Positive Pecam-1 immunostain
In lungs of E14.5 Shh+/− embryos (A), a vascular network is detected in the mesench
Pecam-1 staining was readily detected in the pulmonary mesenchyme (C; right lung l
that is appropriate to the size of the primitive lung tubules (D and F, respectively
morphogenesis of the epithelial tubules (C and E). Brown staining is positive Pecam(Fig. 1F) and sectioning of the E13.5 LacZ stained lungs
showed that vessels ran in close proximity to the airway tubules
and wrapped around the tips of the tubules (Fig. 1I). From these
results we concluded that early (E11.5–E13.5) Shh-deficient
lungs have a vascular network that is appropriate for the extent
of epithelial branching. Since Gli2 and Gli3 are thought to be
the primary transcriptional mediators of Shh signaling in the
developing lung (Van Tuyl and Post, 2000), we also performed
mutant analysis for both transcription factors using Gli/Tie2-
lacZ compound mice. Similar to findings with Shh−/− mice,
deletion of either Gli2 or Gli3 had no influence on early
pulmonary vascular development (not shown).
Pecam-1 staining of Shh-deficient lungs
To confirm that Shh-deficient lungs develop a vascular
network appropriate for the extent of tubular epithelial
branching, we performed immunohistochemistry for Pecam-1.ing (7-μm sections) is detected in endothelial cells, lining the pulmonary vessels.
yme surrounding the primitive lung tubules (B). In E14.5 Shh−/− lungs, positive
obe; E; left lung lobe). With higher magnification a vascular network is detected
). Note the small lung size of Shh−/− and the dramatic decrease in branching
-1 immunostaining. Scale bar: (A, C, E) 100 μm; (B, D, F) 40 μm.
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Pecam-1 was observed in the pulmonary mesenchymal mass
where it stained the endothelial lining of the vessels wrapping
around epithelial tubules (Figs. 2A and B). In Shh−/− lungs, a
similar pattern of immunopositive Pecam-1 staining was
observed (Figs. 2C–F). Immunopositive vessels ran along the
few epithelial tubules that were present in the highly hypoplastic
lung (Figs. 2D and F). Comparison of the amount of vessels in
Shh+/− lungs (Fig. 2A) to the amount of vessels in Shh−/− lungs
(Figs. 2C and E) demonstrated that fewer vessels were present
in the Shh−/− lungs. However, looking at the individual lungs,
the relative epithelial bud/vessel ratio was fairly similar in both
lungs. To confirm this observation we performed real-time RT-
PCR for Pecam-1 in E12.5–13.5 Shh+/+, Shh+/− and Shh−/−
lungs. Comparable levels of Pecam-1 mRNA expression were
found between the three groups of lungs (Fig. 3A). These resultsFig. 3. Decreased Ang-1 expression level in early E12.5–13.5 Shh−/− lungs. Message
qRT-PCR results for Pecam-1 expression. No differences were observed in Pecam-1
representation of qRT-PCR results for Vegf and Flk-1 (Vegfr2) expression. Message le
similar in E12.5–13.5 Shh+/+, Shh+/− and Shh−/− lungs. Flk-1 (Vegfr2) levels were si
(q)RT-PCR results for Ang-1, Ang-2 and Tie2 mRNA expression. Ang-1 expression w
to Shh+/+ and Shh+/−), whereas Ang-2 (D) and Tie2 (E) mRNA levels were not differen
PCR results for Fgf10 and Fgfr2 mRNA expression. Fgf10 (F) and Fgfr2 (G) express
Shh+/− lungs (#p<0.05).corroborate our Tie2-LacZ lung observations of early vascular
development not being affected in Shh-deficient lungs.
Vegf expression in Shh-deficient lungs
Recently, it has been reported that Shh influences the
expression of Vegf, a potent growth factor for vascular
development (Pola et al., 2001). Therefore, we performed
real-time RT-PCR for total Vegf in E12.5–13.5 Shh+/+, Shh+/−,
and Shh−/− lungs. No significant differences in total Vegf
mRNA expression were found between Shh+/+, Shh+/−, and
Shh−/− lungs (Fig. 3B). Since Vegf exists in three different
isoforms due to differential splicing, we tested the possibility
that Vegf isoform expression could be different among the
Shh+/+, Shh+/− and Shh−/− lungs. No significant differences in
mRNA expression of any of the VEGF isoforms (Vegf120,levels were quantified by real-time (q)RT-PCR. (A) Schematic representation of
mRNA expression between Shh+/+, Shh+/− and Shh−/− lungs. (B–C) Schematic
vels of total Vegf (B) and Vegf isoforms −120, −164 and −188 (not shown) were
milarly unchanged in Shh−/− lungs. (D–E) Schematic representation of real-time
as significantly downregulated in E12.5–13.5 Shh−/− lungs (*p<0.05 compared
t from those in Shh+/+ and Shh+/− lungs. (F–G) Schematic representation of qRT-
ion levels were upregulated in E12.5–13.5 Shh−/− lungs compared to Shh+/+ and
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(not shown). Expression of the Vegf receptor Vegfr2 [Flk-1/
KDR] was marginally downregulated compared to Shh+/+ lungs
(Fig. 3C). These results indicate that the Vegf/Vegfr2 signaling
loop is relatively unaffected, hence contributing to a proper
pulmonary vascular network in early Shh-deficient lungs.
Ang expression in Shh-deficient lungs
Angiopoietins are a relatively new group of angiogenic
cytokines that have been shown to contribute to vascular
maturation and stability (Thurston et al., 1999; Maisonpierre et
al., 1997; Suri et al., 1998). Since it was shown in vitro, that
exogenous Shh induced expression of Ang1 and Ang2 from
interstitial mesenchymal cells (Pola et al., 2001), we performed
real-time RT-PCR for Ang1 and its natural antagonist Ang2 in
the same E12.5–13.5 Shh lung samples that were used to assess
Pecam-1, Vegf and Vegfr2 mRNA levels. Ang1, but not Ang2,
mRNA expression was significantly decreased in Shh−/− lungs
compared to Shh+/+ (p=0.002) and Shh+/− (p=0.003) lungs
(Fig. 3D). No difference was observed in the mRNA expression
of Tie2, the receptor for Ang1 and Ang2 (Fig. 3E). As a control
experiment for the validity of the real-time RT-PCR, we
compared the mRNA expression levels of Fgf10 and the Fgf
receptor, Fgfr2, between Shh+/+, Shh+/− and Shh−/− lungs. In
agreement with previous reports (Litingtung et al., 1998), Fgf10
and Fgfr2 mRNA expression were upregulated in E12.5–13.5
Shh−/− lungs compared to Shh+/+ and Shh+/− lungs (Figs. 3FFig. 4. Abnormal in vitro vascular development in cultures Shh−/− lung explants. B
Shh−/− lungs were carried out in vitro. (A–C) X-gal stained lungs of E12.5 Shh+/+
network is present in wild-type (Shh+/+) lung explants after 3 days in culture (A
surrounding epithelial tubules (B, C). (D–F) X-gal stained lungs of E12.5 Shh−/−/T
explants, the vascular network in Shh−/− lung explants rapidly deteriorates with furth
of vascular structures (and epithelial branching morphogenesis) after 3 (E) and 5 (F)
Blue color is positive X-gal staining in endothelial cells. Scale bar: (A, D) 160 μmand G). Altogether, these data suggest an altered balance
between Ang1 and Ang2 in early Shh-deficient lungs that may
lead to vascular abnormalities at later gestation.
Vascular development in cultured Shh-deficient lungs
Unfortunately, most Shh−/− mice die around E14.5 from
multiple organ failure (Litingtung et al., 1998). To test whether
later (>E14.5) vascular development in Shh-deficient lungs was
abnormal because of a disturbance in the balance between Ang1
and Ang2, we followed the vascular and airway branching
morphogenesis of Shh−/− lungs in vitro. No differences were
notable in explants of E12.5 Shh+/+ and Shh+/− lungs after a 3-
to 5-day culture (not shown). In contrast, vascular development
was severely affected in E12.5 Shh−/− lung explants after 3–
5 days in culture (Fig. 4). E12.5 lung explants from Shh+/−/
Tie2-LacZ compound mice formed an extensive and complex
pattern of vessels, visualized by whole mount LacZ staining,
after 3 days in culture (Fig. 4A). Sectioning of these lung
explants revealed a proper capillary network in the mesenchyme
surrounding developing epithelial tubules (Fig. 4B). After
5 days in culture, the capillary network is even more extended,
while the mesenchymal layers separating the airways are
thinning further (Fig. 4C). Cultured E12.5 Shh−/− lung explants,
compared to Shh+/− lung explants, were severely hypoplastic
(Figs. 4D vs. A) and lacked airway branching morphogenesis
(Figs. 4E vs. B). Also, vascular development dramatically
deteriorated in E12.5 Shh−/− lung explants after 3 days inecause almost no Shh−/− embryos survive until term, further experiments with
/Tie2-LacZ mice after 3 (A–B) or 5 (C) days in culture. A complex vascular
). After sectioning, a fine vascular network is observed in the mesenchyme
ie2-LacZ mice after 3 (D–E) or 5 (F) days in culture. In contrast to wild-type
er culturing in vitro (A vs. D). Upon sectioning of Shh−/− lung explants, the lack
days in culture is even more evident. Sections were counterstained with eosin.
; (B–C, E–F) 100 μm.
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discontinued, hypoplastic vascular network remained in E12.5
Shh−/− lung explants after 3–5 days in culture (Figs. 4E and F).
These data suggest that later pulmonary vascular development
is disturbed in Shh−/− mice.
Rescue of branching morphogenesis of Shh-deficient lungs
It is possible that the epithelial branching defect in Shh−/−
lung explants is partially resulting from the reduced vascular
formation. Since Ang1 mRNAwas found to be downregulated
in E12.5/13.5 Shh−/− lungs, we attempted a rescue experiment
in which Shh-deficient lung explants were cultured in the
presence or absence of recombinant Ang1. E12.5 Shh−/− lungs,
cultured without exogenous Ang1, showed a few dilated tubular
structures after 4 days in culture (Figs. 5Aa–d; Fig. 6). Addition
of 500 ng/ml of Ang1 to the culture medium did not increase
tubular branching in Shh−/− lung explants (Figs. 5Ba–d; Fig. 6).
Since Fgf2 is a mitogen for fetal pulmonary endothelial cells
(Tanswell et al., 1991), we then decided to investigate ifFig. 5. Partial restoration of tubular branching in Shh−/− lung explants by Fgf-2. (A
morphogenesis and are connected to a single tracheoesophageal tube (arrow). Untre
distal tips of the explants (Ab–c), but in general, growth and branching morphogen
rhAng-1 (500 ng/ml) to E12.5 Shh−/− lung explants did not affect (after 1, 2 and 4 da
lung explants were cultured with rhFgf-2 (250 ng/ml), tubular growth and branching
amount of mesenchyme surrounding the epithelial tubules increased (arrows in panel
simultaneously, increased the size and degree of tubular branching to a greater extent t
(a) 200 μm; (b–d) 155 μm.branching morphogenesis of Shh−/− lung explants can be
stimulated with exogenous Fgf2. Culturing of Shh null lung
explants with exogenous Fgf2 resulted in an increase in
mesenchymal mass surrounding the epithelial tubular structures
(Figs. 5Ca–c). From 3 days onwards, the Shh−/− lung explants
cultured with exogenous Fgf2 exhibited an increase in size and
number of tubular structures (Figs. 5Cd) compared to Shh−/−
lung explants cultured without Fgf2 (Figs. 5Aa–d; Fig. 6).
Simultaneous addition of exogenous Fgf2 and Ang1 to the
culture medium of Shh−/− lung explants improved tubular
number and extension even further than with Fgf2 alone (Figs.
5Da–d, Fig. 6). Interestingly, global Fgf2 mRNA expression
was not significantly altered in E12.5–13.5 Shh-deficient lungs
compared to Shh+/+ and Shh+/− lungs (Fig. 7A). To be sure that
Fgf2 stimulated vascular development in Shh−/− lung explants
we investigated its effect on vessel development using Shh/
Tie2LacZ lung explants. Addition of 250 ng/ml of Fgf2 to the
culture medium of E12.5 Shh+/−/Tie2LacZ lung explants
resulted in an expanded and more complex vascular bed
(Figs. 7B vs. C), suggesting that Shh+/− lung explants, whicha–d) E12.5 Shh−/− explants (Aa) are small in size, exhibit reduced branching
ated Shh−/− lung explants do occasionally show some tubular branching at the
esis remain severely reduced after 4 days in culture (Ad). (Ba–d) Addition of
ys (Bb–d, respectively) branching morphogenesis. (Ca–d) When E12. 5 Shh−/−
increased dramatically (after 1, 3 and 4 days in culture; Cb–d respectively). The
s Cb–d). (Da–d) Addition of both rhAng-1 (500 ng/ml) and rhFgf-2 (250 ng/ml)
han rhFgf-2 alone (after 1, 3 and 4 days in culture; Db–d respectively). Scale bar:
Fig. 6. Stimulation of tubular growth and branching in Shh−/− lung explants by
Fgf-2 and Ang-1. Shh−/− (B) and Shh−/+ (A) lung explants were cultured with
and without Fgf-2 (250 ng/ml), Ang-1 (500 ng/ml) or Fgf-2 and Ang-1
combined. Tubular branching was quantified by daily counting of terminal lung
tubules. Addition of Fgf-2 and Ang-1 to the Shh−/+ (A) lungs did not affect
branching, while Fgf-2 alone or combined with Ang-1 stimulated the number of
terminal tubules in Shh−/− (B) lung explants. Data are mean of three separate
explant cultures.
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respond to Fgf2. Likewise, the pulmonary vascular network was
significantly increased in Shh−/− lungs after culturing with Fgf2
(Figs. 7D vs. E). Sectioning of LacZ stained Shh−/− lung
explants after 5 days in culture with and without exogenous
Fgf2 demonstrated that the increase in vascular development
was associated with increased tubular growth and branching
(Figs. 7F vs. G). To exclude that Fgf2 and Ang1 stimulated
airway branching, we incubated distal mesenchyme-free
endoderm from E12 mouse lung with and without 200 ng/ml
of Fgf1, Fgf2, Fgf7 or Ang1. All three Fgfs promoted epithelial
expansion (Figs. 8A–D), but only Fgf7 induced epithelial
budding (Figs. 8E, F). As pulmonary endodermal cells do not
have Tie2 receptors, Ang1 had no effect on the endodermal
cultures (not shown). Thus, the Shh−/− lungs respond to the
angiogenic factors Fgf2 and Ang1 with increased vasculariza-
tion which then stimulates tubular growth and branching.
Since Shh has been shown to affect subepithelial myofibro-
blasts and smooth muscle cell differentiation in a variety of
organs, including lung (Miller et al., 2004; Apelqvist et al.,
1997; Madison et al., 2005), we analyzed the effect of Fgf2 and
Ang1 on smooth muscle cell formation in the Shh−/− lung
explants. As anticipated E12.5 Shh−/− lungs, cultured for
4 days, exhibited a dramatically reduced α-Sma immunoreac-tivity (Figs. 8H, K vs. G, J). Although the addition of Fgf2 plus
Ang1 partially restored branching in Shh−/− lung explants, they
did not significantly improve smooth muscle differentiation in
these lungs (Figs. 8I, L).
Discussion
Herein, we report that Shh deficiency in mice leads to
abnormalities in pulmonary vascular development. A loss of
Shh does not affect early pulmonary vasculogenesis and
angiogenesis, but reduces the expression of the vascular
stabilizing factor Ang1, thereby leading to a diminished
stabilization of the primitive network at later gestation.
Intriguingly, restoration of the pulmonary vascular defect in
Shh-deficient lungs with angiogenic factors, such as Fgf2 and
Ang1, partially recovers the branching abnormality reported
previously for Shh null mice (Litingtung et al., 1998; Pepicelli
et al., 1998), implying that proper vascularization is important
for normal branching morphogenesis.
Several reports support the idea that Shh is involved in
controlling vascularization during development. Ectopic
expression of Shh causes hypervascularization of the dorsal
neural tube in mice (Rowitch et al., 1999) and Shh-deficient
zebrafish fail to form the dorsal aorta (Brown et al., 2000). Shh
induces a robust neovascularization of ischemic hind limbs of
aged mice (Pola et al., 2001) and is essential for coronary
vascular development (Lavine et al., 2006). Albeit Kanda et al.
(2003) reported that Shh did not induce proliferation or
migration of endothelial cells, they did observe that Shh
promoted capillary morphogenesis of cultured endothelial cells.
In the present study, the early development of the pulmonary
vascular network was unaffected in Shh-deficient mice. Vegf
and its endothelial cell-specific receptor Vegfr2 are important
for vasculogenesis and angiogenesis. Mice engineered to lack
either gene fail to develop a vasculature (Carmeliet et al., 1996;
Ferrara et al., 1996; Shalaby et al., 1995). Alternative splicing of
the Vegf gene produces various Vegf isoforms with Vegf120,
Vegf164 and Vegf188 being expressed in the developing lung (Ng
et al., 2001). Vegf164 and Vegf188 are thought to be important for
pulmonary vascularization (Galambos et al., 2002). The
observation that the expression of neither Vegf isoform was
affected in E12.5–E13.5 Shh-deficient lungs may explain the
normal development of the primitive pulmonary vascular
network in these lungs. Ang1 and 2 bind to the Tie2 receptor,
which is expressed by the vascular endothelium. Unlike mouse
embryos lacking Vegf or Vegfr2, embryos lacking Ang1 or Tie2
develop a rather normal primary vasculature (Suri et al., 1996;
Sato et al., 1995; Dumont et al., 1994). However, the vessels are
immature, leaky and hemorrhagic. Ang2 acts as an antagonist of
Tie2 signaling (Maisonpierre et al., 1997). Thus, a balance
between Ang1 and Ang2 determines vascular maturation and
stability (Yancopoulos et al., 1998, 2000). In the present study,
Ang1, but not Ang2, expression was downregulated in E12.5–
13.5 Shh-deficient lungs and we speculate that this alteration of
the balance in favor of Ang2 causes vascular destabilization
resulting in the deterioration of the pulmonary vascular network
at later gestation. In human (Unger et al., 2003) and murine lung
Fig. 7. Exogenous Fgf-2 increases the vascular network as well as tubular growth and branching in Shh−/− lungs. (A) Schematic representation of real-time (q)RT-PCR
results for Fgf-2 mRNA expression in E12.5–13.5 Shh mice. No significant differences were observed between E12.5–13.5 Shh+/+, Shh+/−, and Shh−/− lungs. (B–C)
X-gal stained lungs of E12.5 Shh+/−/Tie2-LacZ mice after 6 days in culture. A complex vascular network is present in Shh+/− (B) lung explants. Addition of rhFgf-2
(250 ng/ml) to cultured Shh+/− lung explants greatly enhanced the vascular network (C). (D–G) X-gal stained lungs of E12.5 Shh−/−/Tie2-LacZ mice after 6 days in
culture. Few, disorganized vessels are present in untreated Shh−/− lung explants (D). After sectioning, the scarcity of vessels and the lack of branching morphogenesis
are obvious (F). The addition of rhFgf-2 (250 ng/ml) to the culture significantly enhanced the vascular complex in Shh−/− lungs (E). Sections of the X-gal stained
explants revealed a dramatic increase in vascularization and tubular branching morphogenesis of the Fgf-2 treated Shh−/− lung explants (G). Sections were
counterstained with eosin. Blue color is positive x-gal staining in endothelial cells. Scale bar: (B, C) 200 μm; (D, E) 160 μm; (F, G) 100 μm.
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ular, early canalicular period of development, a time of intense
pulmonary vascularization. At this later gestational age, a loss
of Shh likely causes a more pronounced reduction of Ang1 and,
therefore, augmentation of the vascular defect and explains why
the vascular abnormality was only observed after culturing the
E12.5–13.5 Shh−/− lungs for several days. We did not
investigate the expression of angiogenic factors in these
cultured lungs. However, a recent study showed a reduction
of Vegf120 mRNA expression in E18.5 lungs of Shh null mice
(Miller et al., 2004), suggesting that Shh affects also Vegf
expression at later gestation.
In E12.5 mouse lungs, Ang1 mRNA expression localizes to
the mesenchyme and smooth muscle cells surrounding most
blood vessels (Maisonpierre et al., 1997). The mesenchymal
compartment is a direct cellular target of Shh (Litingtung et al.,1998; Pepicelli et al., 1998) and Shh is required for the
formation of smooth muscle cells in several organs (Apelqvist et
al., 1997; Madison et al., 2005). Our observation of reduced
anti-smooth muscle cell immunoreactivity in Shh null lungs is
in agreement with a recent report (Miller et al., 2004) showing
that Shh influences bronchial and vascular smooth muscle cell
formation. Whether Shh mediates its effect on these cells via
Ang1 remains unknown but Ang1 has been shown to play a role
in the interaction of endothelial cells and surrounding support
cells such as pericytes and smooth muscle cells (Holash et al.,
1999). Ang1 is a chemotactic, but not proliferative, factor for
endothelial cells. The chemotactic effect is abolished by excess
soluble Tie2 receptor, indicating that this is the cognate receptor
for Ang1 (Witzenbichler et al., 1998). It has been shown that a
reduction in Ang1 is a major cause of abnormalities in
vascularization. Ang1 mutants have an abnormal vasculature
Fig. 8. Effects of exogenous Fgf2 on endodermal branching (A–F) and smooth muscle cell formation (G–L). Mesenchyme-free endoderm grown for 72 h in control
medium (A) or medium supplemented with 200 ng/ml of Fgf1 (B), Fgf2 (C) or Fgf7 (D). All three Fgfs stimulated epithelial expansion, but only Fgf7 stimulated
endodermal budding. The budding was more evident after sectioning of the endodermal cultures. Control (E) and Fgf1 and Fgf2 treated cultures (not shown) formed
hollow spheroidal structures, while Fgf7 produced numerous budding structures (F). Shh+/− (G, J) and Shh−/− lungs (H–L) cultured for 4 days in the presence (I, L) or
absence (H, K) of both 250 ng/ml Fgf2 and 500 ng/ml Ang1 were immunostained for α-smooth muscle actin. Positive α-Sma immunoreactivity was present in Shh+/+
lungs (G, J), but absent in Shh−/− lungs (H, K). Sma expression was not restored by addition of both Fgf2 and Ang1 to the cultures (I, L). Data are two separate explant
experiments: (G, G, I) counterstaining with hematoxylin; (J, K, L) no counterstaining.
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of periendothelial smooth muscle and pericyte cells (Suri et al.,
1996). Shh may induce Ang1 via COUP-TFII activation in
mesenchymal cells (Krishnan et al., 1997; Pereira et al., 1999).COUP-TFII is a member of the steroid/thyroid hormone
receptor superfamily, which consists of a large group of
ligand-activated transcription factors (Tsai and Tsai, 1997).
During early lung development COUP-TFII is expressed in the
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development (Malpel et al., 2000; Pereira et al., 1995), at the
time that pulmonary Shh expression starts to decline (Unger et
al., 2003). A Shh response element has been identified in the
COUP-TFII promoter that binds to a factor distinct from Gli
(Witzenbichler et al., 1998). Two-thirds of the heterozygous
COUP-TFII mice die before weaning, and a homozygous
deletion of COUP-TFII is lethal around 10 days of gestation
(Pereira et al., 1999). Ang1 is downregulated in COUP-TFII
mutants and angiogenesis and vascular remodeling are defective
(Pereira et al., 1999). Vasculogenesis appeared normal in
COUP-TFII mutants, i.e., development of a primitive vascular
plexus with appropriate differentiation marker (Vegfr1, Vegfr2,
and Pecam-1) genes (Pereira et al., 1995). However, the
formation of a microcapillary network was impaired (Pereira et
al., 1995). Ang1 was downregulated while Tie2 expression
appeared normal. This suggests that basal Ang1 levels are
sufficient to maintain Tie2 expression, but not to maintain an
effective vascular plexus. Vegf was upregulated in E9.5 COUP-
TFII mutants. This combination of normal/elevated levels of
Tie2 and Vegf, but a decreased level of Ang1 expression is very
similar to the present findings in Shh-deficient lungs. Thus, it is
possible that Shh affects Ang1-mediated pulmonary vascular-
ization via COUP-TFII. However, our observation that addition
of Ang1 alone or in combination with Fgf2 did not restore the
smooth muscle cell defect in the Shh null lungs, argues against a
role for Ang1 in pulmonary smooth muscle cell differentiation.
The apparent rescue of the vascular abnormality as well as
tubular growth and branching in Shh-deficient lung with Fgf2
and Ang1 is intriguing. Fgf2 and its receptor Fgfr1c have
been found to be expressed in both epithelial and mesench-
ymal compartment of the fetal lung (Han et al., 1992;
Gonzalez et al., 1996; Powell et al., 1998). Lebeche et al.
(1999) showed that Shh did not affect Fgf2 mRNA
expression in embryonic lung mesenchymal cells, which is
in agreement with our present finding that Shh deficiency
does not alter overall Fgf2 expression in E12.5–13.5 lungs.
However, we cannot exclude Shh deficiency-induced changes
in spatial Fgf2 expression. Furthermore, since Fgf2 expression
increases at the time of capillary formation at late gestation
(Lebeche et al., 1999), it is possible that Fgf2 expression is
downregulated in Shh−/− lungs at later gestation. Fgf2 binds
to Fgfr1c and Fgfr2c, but not Fgfr2b, receptors (Zhang et al.,
2006). The latter Fgfr2 splice variant localizes to the lung
epithelium (Orr-Urtreger et al., 1993) and binds various Fgfs,
including Fgf1, Fgf7 and Fgf10 (Zhang et al., 2006). Herein,
we found that Fgf1 and Fgf7 stimulated epithelial expansion
(growth) in mesenchyme-free cultures, in agreement with
previous reports (Nogawa and Ito, 1995; Bellusci et al.,
1997a,b). Although previous studies have reported that Fgf7
is not able to induce budding in mesenchyme-free epithelial
cultures (Bellusci et al., 1997a,b), we observed that 200 ng/ml
Fgf7 stimulated the formation of small buds. Such generalized
budding of mesenchyme-free epithelium in response to 50 ng/
ml Fgf7 has been reported by Park et al. (1998). Herein, we
demonstrate that Fgf2 stimulates speroidal epithelial growth,
but not budding of the mesenchyme-free endoderm. Thus, thepartial recovery of the tubular branching in Shh-deficient
lungs by exogenous Fgf2 is likely not due to a direct action
of Fgf2 on early epithelial branching. We speculate that
exogenous Fgf2 increases the amount of mesenchymal/
vascular mass surrounding the growing lung buds of Shh
null lungs, thereby providing a tissue base for vessels to
grow, stimulated by exogenous Ang1 and endogenous Vegf.
Indeed, Fgf2 has been shown to influence angiogenesis via
Vegf and Vegfr2 (Seghezzi et al., 1998; Tille et al., 2001).
The increase in branching morphogenesis is likely an indirect
result of the stimulated mesenchymal/vascular growth. It has
been suggested that Fgf2 stimulates smooth muscle cell
proliferation of the vessel wall (Bikfalvi et al., 1997),
allowing Ang1 to stabilize the vascular bed in Shh-deficient
lungs. This scenario is unlikely as Fgf2 alone or in
combination of Ang1 did not correct the smooth cell
differentiation defect seen in the Shh−/− lungs. In conclusion,
the data are compatible with angiogenic factors stimulating
vascularization and, thereby, tubular growth and branching in
Shh null lungs.
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